Bilateral internal thoracic artery on the left side: A propensity score–matched study of impact of the third conduit on the right side  by Di Mauro, Michele et al.
Di Mauro et al Acquired Cardiovascular Disease
A
C
DBilateral internal thoracic artery on the left side: A propensity
score–matched study of impact of the third conduit on the right side
Michele Di Mauro, MD, Marco Contini, MD, Angela L. Iaco`, MD, Antonio Bivona, MD, Massimo Gagliardi, MD,
Egidio Varone, MD, Paolo Bosco, MD, and Antonio M. Calafiore, MD
Objective: This study was undertaken to evaluate long-term results of bilateral internal thoracic artery grafting
with saphenous vein or another arterial conduit as the third conduit.
Methods: From September 1991 to December 2002, a total of 1015 patients underwent first isolated coronary
artery bypass grafting for triple-vessel disease, with bilateral internal thoracic artery plus saphenous vein in
643 cases and bilateral internal thoracic artery plus arterial conduit in 372. A nonparsimonious regression model
was built to determine propensity score, then sample matching (saphenous vein vs arterial conduit) was performed
to select 885 patients (590 with saphenous vein, 295 with arterial conduit). Groups had similar preoperative and
operative characteristics.
Results: Eight-year freedoms from cardiac death were significantly higher when saphenous vein was used
(98.6%  0.5% with saphenous vein vs 95.3%  1.3% with arterial conduit, P ¼ .009), but this difference
was related exclusively to right gastroepiploic artery grafting (94.5%  1.6% vs saphenous vein, P ¼ .004).
This difference disappeared for radial artery grafting (97.6% 1.6% vs saphenous vein, P¼ .492). Cox analysis
confirmed that supplementary gastroepiploic artery was an independent variable for lower freedoms from all-
cause mortality and from cardiac death. Presence of high-degree stenosis (80%) appeared to influence this result.
Conclusions: In patients with triple-vessel disease undergoing first isolated coronary artery bypass grafting, sup-
plementary venous grafts seem to provide more stability than gastroepiploic artery, which may even impair long-
term outcome.The number of coronary artery bypass grafting (CABG) pro-
cedures is decreasing because of increased use of percutane-
ous coronary revascularization, especially since the advent
of drug eluting stents.1 Conversely, the incidence of patients
with triple-vessel coronary disease undergoing CABG has
broadened remarkably in the last decade. In this scenario,
surgeons must clearly identify any possible surgical strategy
to improve long-term outcome. The superiority of bilateral
internal thoracic artery (BITA) grafts relative to single inter-
nal thoracic artery (ITA) grafts has already been demon-
strated,2-5 especially when BITA, is grafted to coronary
arteries on the left side.4,5 The best supplementary graft
for the right coronary artery (RCA) system, however, is still
uncertain.
Right ITA, either in situ6,7 or Y grafted,8 does not offer
any clinical or angiographic benefit relative to saphenous
vein (SV). In particular, reduced right ITA patency has
been observed when grafted to distal RCA system.6,8 Al-
though in the late 1990s some authors9,10 supported the
use of radial artery (RA) as complementary conduit in cases
of left-side BITA grafting, long-term angiographic results
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doi:10.1016/j.jtcvs.2008.09.014The Journal of Thoracic andare still uncertain.11,12 Despite reasonable patency rate,13
the use of right gastroepiploic artery (RGEA) should be lim-
ited to graft coronary stenosis of at least 70%; otherwise, the
presence of an important coronary competitive flow may
cause graft failure, even in patients with intact, patent
grafts.14,15
To evaluate the graft of choice for revascularization of the
RCA system when BITA is grafted to the left-side coronary
system, this retrospective study compared long-term results
of two groups of patients in which the third conduit was
another arterial conduit (AC) or SV.
MATERIALS AND METHODS
Population
From September 1991 to December 2002, a subset of 1015 (71%) of
a total of 1496 patients at University of Chieti with triple-vessel coronary
disease underwent first isolated CABG through a median sternotomy with
BITA used for left-side myocardial revascularization. The RCA system
was grafted with SV in 643 case (63.3%) and with AC in the remaining
372 (36.7%, RGEA in 258 and RA in 114). In the first part of the analysis,
RA and RGEA conduits were pooled because of similar histologic struc-
tures,16 similar reactivities to vasoconstrictor stimuli,16 and similar low pa-
tency rates when grafted onto low-grade coronary stenoses, especially on
the RCA system.11,16 Further analysis was performed to evaluate separately
the clinical impact of each type of AC. The three groups were similar with
respect to most preoperative and operative features except for age (SV 63
9 years vs RGEA 60  9 years vs RA 61  9 years, P< .001), number of
anastomoses per patient (SV 3.6 0.8 vs RGEA 3.0 0.7 vs RA 3.4 0.5,
P ¼ .005), prevalence of previous acute myocardial infarction (AMI, SV
46.2% vs RGEA 58.1% vs RA 61.4%, P< .001), prevalence of chronic
renal failure (SV 3.4% vs RGEA 0.4% vs RA 0%, P ¼ .003), and rate
of off-pump CABG (SV 26.4% vs RGEA 17.4% vs RA 19.3%, P¼ .009).Cardiovascular Surgery c Volume 137, Number 4 869
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DAbbreviations and Acronyms
AC ¼ arterial conduit
AMI ¼ acute myocardial infarction
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
ITA ¼ internal thoracic artery
RA ¼ radial artery
RCA ¼ right coronary artery
RGEA ¼ right gastroepiploic artery
ROC ¼ receiver operating characteristic
SV ¼ saphenous vein
A saturated regression model was solved to generate a propensity score
for each patient, representing the probability of undergoing grafting with
BITA plus SV. The propensity score was used to yield two propensity-
matched groups by means of 2:1 sample matching; thus, a cohort of 885
patients (87.2%) was selected from the entire population as follows: 590 pa-
tients with BITA plus SV (91.8%) and 295 with BITA plus AC (79.3%)
(RGEA in 208 cases and RA in 87). The two subsets showed similar preop-
erative and operative characteristics; moreover, no statistical differences
were found among patients who received RA, RGEA, and SV grafts (Table
1). These cases were included in previous publications of ours. Use of our
database was authorized by the institutional review board in October 2004.
This authorization waived patient consent.
Surgical Technique
A contraindication for RA harvesting was a positive Allen test result.17
RGEA was not harvested in presence of gastritis or ulcer, in cases of gall-
bladder calculosis, or in the expectation of further abdominal surgery.
Whenever there was no contraindication to RA or RGEA harvesting, the ar-
terial graft was chosen according to surgeon preference. Calcium blockers
have been always used in patients undergoing harvest of RA or RGEA
(60 mg 3 times/d, orally given for 6 months after the operation). The ITA
was harvested in a pedicled fashion in the first 73 patients(8.2%) and as
a skeletonized conduit in the remaining 812 (91.8%).18 BITA was used
as a Y graft19 in 372 cases (42.0%), (BITA plus AC group n ¼ 68,
23.1%, and BITA plus SV group n ¼ 304, 51.5%, P< .001). The RA
and RGEA were always harvested pedicled, as previously described17;
the SV was always harvested from the lower leg in a skeletonized fashion.
RGEA was grafted as in situ conduit. The left anterior descending coronary
artery was grafted with ITA in all cases except 23, in which the vessel was
extremely calcified or undersized and a diagonal branch was grafted instead
of the left anterior descending coronary artery. RGEA was used preferably
for posterior descending coronary artery grafting (75.9%) because of its an-
atomic position and its usually small size. RA was mainly grafted to the
RCA (63.9%) because its size was better fitted to the RCA trunk. Most
of the anastomoses performed with SV (61.4%) were onto the posterior de-
scending coronary artery because of the SV’s caliber from being harvested
from the leg. Moreover, some peripheral branches, such as retroventricular,
posterolateral, and acute marginal, were included as part of the RCA. Car-
diopulmonary bypass was used in 676 cases (76.4%); myocardial revascu-
larization was performed without cardiopulmonary bypass in the remaining
209 (23.6%). The on-pump and off-pump techniques used have previously
been described.20
End Points
The primary end point was any possible difference between BITA plus
SV and BITA plus AC in terms of long-term outcomes: 8-year freedoms870 The Journal of Thoracic and Cardiovascular Sufrom death from any cause, cardiac death, AMI, surgical or interventional
reoperation, cardiac event, and any event. Cardiac death was defined as
death that was cardiac related or occurred as sudden death. Cardiac event
was defined as the occurrence of at least one of following events: cardiac
death, AMI, or reoperation. Any event was defined as the occurrence of
at least one of the following events: death from any cause, AMI, or reoper-
ation. Myocardial infarction was defined as enzymatic elevation, electrocar-
diographic sign of necrosis, new akinetic segment or segments on
echocardiogram, and ventricular arrhythmias not related to potassium ion.
The secondary end point was long-term clinical outcome with respect to
impairment by any of the three evaluated grafts.
Follow-up
All the patients were followed up in our outpatient clinic 3, 6, and 12
months after surgery and thereafter at yearly intervals. The most recent in-
formation was obtained by calling the patient or the referring cardiologist.
Follow-up was 100% complete as of June 30, 2007. Median follow-ups
were 97 months (25th–75th percentiles 78–120 months) overall, 88 months
(70–102 months) for BITA plus SV, and 128 months (111–142 months) for
BITA plus AC (131months, 118–143months for BITA plus RGEA and 116
months, 80–138 months for BITA plus RA, P< .001.
Statistical Analysis
Data are presented as mean  SD. Statistical analysis comparing groups
was performedwith the Pearsonc2 test (or the Fisher exact test) for categoric
variables. Mann–Whitney U and analysis of variance tests (with post hoc
analysis) were used for comparing continuous variables in cases of two
(SV vs AC) or three (SV vs RGEA vs RA) groups, respectively. All the vari-
ables initially entered in the stepwise logistic regression to generate the pro-
pensity model have been reported previously.20 The propensity score model
fit and predictive power were evaluated with the Hosmer–Lemeshow good-
ness-of-fit (0.878) and c-statistic (0.901), respectively. The model was val-
idated in 500 bootstrap samples. Eight-year survival curves were obtained
with the Kaplan–Meier method; significant differences between groups
were evaluated with log-rank tests. In cases of competing risks, cumulative
incidenceswere reported. Time-to-event analysiswas performedwith amul-
tivariable Cox proportional-hazard regression. Candidate variables20 were
tested by univariate approach; Variables with P  .2 were entered into the
Cox regression. The final model was validated in 500 bootstrap samples;
factors appearing in 50% or more of the analyses were considered reliably
statistically significant. The results of Cox analysis were reported as hazard
ratio, 95% confidence interval (CI), and P value. The optimal cutoff degree
of RCA system stenosis to predict worse 8-year cardiac mortality was deter-
mined by receiver operating characteristic (ROC) curve analysis; area under
the curve with corresponding 95% CI and P value along with sensitivity,
specificity, and their respective 95% CIs were reported. Again, the results
of ROC analysis were validated in 500 bootstrap samples. The SPSS soft-
ware package (SPSS Inc, Chicago, Ill) was used.
RESULTS
Early Outcome
Thirty-day mortality was 1.8% (16 cases); 6 (0.7%) of
these patients died of cardiac causes. AMI and cerebrovas-
cular accident occurred in 11 (1.2%) and 14 (1.6%), respec-
tively. The rate of aggregate negative primary end points
(death from any cause, AMI, and cerebrovascular accident)
was 4.0% (35 cases). Sixty-one patients (6.9%) had a major
event (death, low output syndrome, AMI, cerebrovascular
accident, acute renal failure, acute respiratory insufficiency,
ventricular arrhythmias, abdominal complication). Early
outcome was not statistically different among groups.rgery c April 2009
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DTABLE 1. Preoperative characteristics and surgical details
Group P value
BITAþSV BITAþAC BITAþRGEA BITAþRA 1* 2*
No. of patients 590 295 208 87
Age (y, mean  SD) 62.6  8.7 62.1  8.0 61.6  8.1 63.4  7.4 .372 .160
Female sex (No.) 74 (12.5%) 35 (11.9%) 21 (10.1%) 14 (16.1%) .772 .345
LMT disease (No.) 89 (15.1%) 46 (15.6%) 35 (16.8%) 11 (12.6%) .843 .647
EF (%, mean  SD) 60.6  12.8 59.5  12.0 59.7  12.2 59.1  11.4 .559 .831
Urgent operation (No.) 122 (20.7%) 69 (23.4%) 54 (26.0%) 15 (17.2%) .355 .164
Previous MI (No.) 267 (45.3%) 148 (50.2%) 104 (50.0%) 44 (50.6%) .167 .384
Diabetes (No.) 126 (21.4%) 61 (20.7%) 46 (22.1%) 15 (17.2%) .816 .629
COPD (No.) 30 (5.1%) 13 (4.4%) 10 (4.8%) 3 (3.4%) .658 .802
ECV (No.) 106 (18.0%) 54 (18.3%) 36 (17.3%) 18 (20.7%) .902 .783
CRF (No.) 0 1 (0.3%) 1 (0.5%) 0 .333 .196
Logistic EuroSCORE (mean  SD) 3.5  2.9 3.1  2.8 3.1  2.7 3.2  3.1 .107 .270
Additive EuroSCORE (mean  SD) 3.4  2.6 3.3  2.4 3.2  2.4 3.4  2.4 .364 .603
No. of anastomoses per patient (mean  SD) 3.5  2.9 3.5  0.6 3.6  0.7 3.4  0.6 .226 .087
OPCAB (No.) 149 (25.3%) 60 (20.3%) 42 (20.2%) 18 (20.6%) .183 .176
BITA, Bilateral internal thoracic artery; SV, saphenous vein; AC, arterial conduit; RGEA, right gastroepiploic artery; RA, radial artery; LMT, left main trunk; EF, ejection fraction;
MI,myocardial infarction; COPD, chronic obstructive pulmonary disease; ECV, extracardiac vasculopathy; CRF, chronic renal failure; OPCAB, off-pump coronary artery bypass
grafting. *Comparison 1 is BITAþSV versus BITAþAC; comparison 2 is BITAþSV versus BITAþRGEA versus BITAþRA; no statistically significant differences were
found in comparing each graft with another one.Late Outcome
Thirty-three of 869 patients who survived the first postop-
erative month (3.8%) died within 8 years after surgery; in 15
cases (1.7%), death was cardiac related. To calculate follow-
up event rate, patient with early events were excluded; thus,
9 of 862 patients (1.0%) had a new AMI (7 in RCA terri-
tory). Further revascularization, either surgical or interven-
tional, was mandatory in 13 cases (1.5%), 2 in the BITA
plus AC group (1 surgical for right ITA failure, 1 interven-
tional for RA occlusion) and 11 in the BITA plus SV group
(all interventional, 2 for BITA failure, 6 for SV failure, and
3 for progression of disease). When only reinterventions for
failure of graft on the RCA system were considered, 8-year
freedom from reoperation was quite similar between groups
(99.0%  0.5% in BITA plus SV group vs 99.6%  0.4%
in BITA plus AC group, P ¼ .367), without a difference be-
tween BITA plus RA and BITA plus RGEA groups. The
BITA plus SV group showed significantly higher 8-year
freedoms from death from any cause and from cardiac death
than the BITA plus AC group. When patients with RA and
RGEA grafts were considered separately, it was evident that
this difference was mainly related to RGEA grafting. All the
other investigated outcome variables were not different be-
tween groups. The results are summarized in Table 2. Cumu-
lative incidence of AMI was 2.2% in the BITA plus SV
group, versus 2.1% in the BITA plus AC group (P ¼
.882), whereas the cumulative incidence of reoperation
was 2.2% in the BITA plus SV group versus 0.7% in the
BITA plus AC group (P ¼ .177). No difference was found
among the three groups. Multivariable Cox proportional
hazard regression confirmed that adding a supplementary
RGEA graft to BITA for RCA system revascularizationThe Journal of Thoracic and Ccan impair long-term survival (hazard ratio 1.6, 95% CI
1.1–3.1, P ¼ .035) and cardiac survival (hazard ratio 2.9,
95% CI 1.2–6.7, P ¼ .017). Other risk factors were age,
ejection fraction of 35% or less, and operative urgency.
Grafting of the posterior descending coronary artery was
not a risk factor.
Target RCA Stenosis and Cardiac Death
ROC curve analysis demonstrated RCA stenosis to be
predictive of higher 8-year cardiac mortality (area under
curve 0.81, 95% CI 0.77–0.85, P ¼ .001) and identified
a cutoff value of RCA system stenosis of 80% (sensitivity
100%, 95% CI 84%–100%, and specificity 60%, 95%
CI 55%–65%). In the presence of RCA system stenosis
less than 80%, 8-year freedom from cardiac death was
98.5%  0.8% in 205 patients with BITA plus SV, versus
89.2%  4.2% in 56 with BITA plus RGEA, versus 100%
in 25 with BITA plus RA (P ¼ .0001; Figure 1). Cox anal-
ysis confirmed that the grafting of RGEA to the RCA system
was a risk factor for lower freedom from cardiac death
among 286 patients with RCA system stenosis less than
80%. In contrast, when RCA system stenosis was at least
80%, freedom from cardiac death was 98.7%  0.6% in
385 patients with BITA plus SV, versus 98.7%  0.9%
in 152 with BITA plus RGEA, versus 96.7%  2.3 in 62
patients with BITA plus RA (P ¼ .491; Figure 2).
Unmatched Analysis
The analysis of results of the entire population before the
matching process showed no statistical differences among
groups with respect to early outcome. The main difference
was in 8-year freedom from cardiac death between BITAardiovascular Surgery c Volume 137, Number 4 871
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DTABLE 2. Eight-year clinical results
Freedom from event (%) P value
BITAþSV (n ¼ 590) BITAþAC (n ¼ 2950) BITAþRGE (n ¼ 208) BITAþRA (n ¼ 87) 1* 2* 3* 4*
All-cause mortality 95.6  0.9 91.7  1.6 91.7  1.9 91.9  2.9 .031 .046 .129 .933
Cardiac death 98.6  0.5 95.3  1.3 94.5  1.6 97.6  1.6 .009 .004 .492 .310
Noncardiac death 96.9  0.7 96.2  1.1 97.0  1.2 94.1  2.6 .549 .937 .172 .222
Cardiac event 95.9  0.8 94.6  0.8 94.0  1.7 96.4  2.0 .593 .417 .793 .482
Any event 91.3  1.2 90.7  1.7 91.2  2.0 89.6  3.3 .849 .915 .565 .569
Data are mean SD. BITA,Bilateral internal thoracic artery; SV, saphenous vein; AC, arterial conduit; RGEA, right gastroepiploic artery; RA, radial artery. *Comparison 1 is BITA
þSV versus BITAþAC; comparison 2 is BITAþSV versus BITAþRGEA; comparison 3 is BITAþSV versus BITAþRA; comparison 4 is BITAþRGEA versus BITA
þ RA.plus SV (98.4%  0.5%) and BITA plus AC (96.3% 
1.0%, P¼ .043); this difference was related to a higher free-
dom from cardiac-related death in the BITA plus SV group
than in the BITA plus RGEA group (95.6%  1.3%, P ¼
.030). All the other investigated late outcomes were similar
among groups. In cases with RCA stenosis less than 80%,
8-year freedom from cardiac death was significantly higher
in the BITA plus SV group than in the BITA plus RGEA
group (98.2%  0.9% vs 85.2%  4.6%, P < .001),
with no difference found between BITA plus SV and
BITA plus RA groups. When the RCA system showed
a low-grade stenosis, 8-year freedoms from cardiac death
were similar among groups.
DISCUSSION
This retrospective analysis shows that the use of RGEA for
RCA system revascularization, at least in the case of BITA
grafted to the left-side coronary system, may yield poorer
long-term survival. This result was exclusively related to re-
duced long-term cardiac survival. Several studies2,4,5,6,13,21-24
have already addressed the issue of the correct graft for the
RCA system from a clinical point of view. Esaki and872 The Journal of Thoracic and Cardiovascular Sucoworkers21 compared 99 patients undergoing grafting with
RGEA with 212 undergoing grafting with SV; they found
7-year survival, freedom from reintervention, and freedom
from cardiac events to be similar between groups. On the other
hand, 7-year freedom from cardiac death was higher in the
RGEA-grafted group the in the SV-grafted group (100% vs
95.5%, P ¼ .032). Esaki and coworkers21 did not, however,
include sudden deaths in the cardiac death population; more-
over, patients in SV-grafted group were significantly older
than those in RGEA-grafted group. Lev-Ran and colleagues22
failed to demonstrate any midterm clinical benefit of adding
RGEA instead of SV to BITA (4-years survival: 91.7% for
SV vs 88% for RGEA, P ¼ .79). Again, different selection
biases (such as higher rates of emergency operations and of
preoperative intra-aortic balloon implants in the SV-grafted
group) reduced remarkably the clinical impact seen in this
study.
Looking at the literature, it is possible to state that
long-term survival with BITA plus RGEA (from 88%
to 91%)13,23,24 and with BITA plus SV (from 85% to
93%)2,4,5,6 are similar. Furthermore, the literature is lacking
in long-term clinical comparisons of RA versus SV for RCAFIGURE 1. Eight-year freedoms from cardiac death for patients with right
coronary artery stenosis not more than 80% with grafts of saphenous vein
(SV, solid line), gastroepiploic artery (dotted line, RGEA), radial artery
(dashed line, RA), and arterial conduits (AC, dashed and dotted line).
FIGURE 2. Eight-year freedoms from cardiac death for patients with right
coronary artery stenosis greater than 80% with grafts of saphenous vein
(SV, solid line), gastroepiploic artery (RGEA, dotted line), radial artery
(RA, dashed line), and arterial conduits (AC, dashed and dotted line).rgery c April 2009
Di Mauro et al Acquired Cardiovascular Disease
A
C
Dgrafting. Even if RA and RGEA have different origins, with
the former a limb artery and the latter a splanchnic one, they
have similar histologic (muscular) structures with fenestrate
internal lamina, in contrast to the ITA, which is an elastic ar-
tery. This difference in structure may explain why RA and
RGEA react more strongly than ITA to vasoconstrictive sub-
stances and are more likely to have postoperative spasm.16
Moreover, RA and RGEA show similar low patency rates
when grafted onto a low-grade coronary stenosis, especially
on the RCA system.11,25,26 The primary end point of our
study was therefore to evaluate the long-term outcomes of
patients undergoing grafting with BITA plus SV versus
those undergoing grafting with BITA plus AC (RA or
RGEA). Although 8-year freedom from cardiac death was
significantly lower in the BITA plus AC group (95.3% 
1.3 vs 98.6%  0.5% in BITA plus SV group, P ¼ .009),
further stratification by single arterial conduit demonstrated
that the RGEA provided lower 8-year freedom from cardiac
death than did SV grafts (94.5%  1.6%, P ¼ .004). It is
well known that RGEA has insufficient flow capacity14,25
and is likely to fail, even with a patent anastomosis, because
of coronary competitive flow.15 Dobutamine stress echocar-
diography was used to evaluate the adequacy of the myocar-
dial blood supply from the arterial graft; when the luminal
diameter was greater than 2.6 mm (sensitivity 70%, specific-
ity 78%), the RGEA could supply a sufficient flow under
stress condition.15 Because the average internal diameter
of RGEA is usually 2.2 mm,26 however, some authors25-27
have suggested using this graft only when the RCA system
has a stenosis of at least 70% to 75%.
It is now difficult to obtain routine angiographic follow-up
for patients who have undergone surgical revascularization.
We therefore decided to evaluate the clinical impact of a third
arterial or venous graft (in addition to BITA grafting of the
left-side system) according to preoperative degree of RCA
system stenosis. The ROC curve identified a cutoff of RCA
system stenosis that was extremely sensitive (100%) to pre-
dict 8-year cardiac death. When RCA stenosis was less than
80%, 8-year freedom from cardiac death was significantly
lower in patients having RGEA grafted onto the RCA system
(89.2% 4.2% RGEA vs 98.5% 0.8% SV, P¼ .001, vs
100% RA, P ¼ .058). This difference disappeared when
RCA stenosis was at least 80% (98.7%  0.9% RGEA vs
98.7%  0.6% SV, P ¼ .996, vs 96.7%  2.3% RA, P ¼
.350). From this subanalysis it is possible to emphasize that
RGEA should be used only in cases of severe RCA stenosis,
at least 80%. Although in our series cardiac outcome of pa-
tients with BITA plus RA did not seem to be influenced by
RCA stenosis (P¼ .373), probably because of our small sam-
ple size, there are larger studies supporting the hypothesis
that RA should be grafted onto high-degree stenosis, espe-
cially in case of RCA system grafting. Maniar and associ-
ates11 reported on midterm angiographic patency of 231
anastomoses grafted with RA, stratified by target coronaryThe Journal of Thoracic andvessel (left descending artery 83.3%, circumflex system
75.2%, RCA system 72.7%, P ¼ .02) and by coronary ste-
nosis (moderate 57.3%, severe 68.8%, critical 83.0%, P<
.001). Multivariate analysis confirmed that grafting of the
RCA system and coronary stenosis no greater than 70%
were risk factors for lower midterm cumulative patency of
RA. This second finding is supported by similar studies.10,12
Concerning the SV, the relationship between its patency
and native coronary artery stenosis and also the effect of
flow competition on SV remain controversial.28-30 In a recent
report, Shimizu and colleagues28 assessed, by means of
a Doppler-tipped guidewire during angiography, the graft
flow volume at rest and during hyperemia in 23 RGEA
and 26 SV grafts, stratifying the results by coronary stenosis.
In the presence of coronary stenosis between 50% and 75%,
RGEA had a flow volume roughly half that of the SV at rest
and a third that during hyperthermia; moreover, RGEA flow
volume was higher in stenosis greater than 75% than in
moderate stenosis both at rest (36 17 vs 17 11) and dur-
ing hyperthermia (78  30 vs 32  19), whereas SV flow
volume (mL/min) remained unchanged. In addition, Dion
and associates7 reported surprisingly good patency of SV
grafted onto RCA territory, similar to that of ITA, at
a mean of 7.5 years after surgery. Another important issue
of our study was that patients who received a third graft of
AC showed lower cumulative incidence of reintervention
than did patients with SV, even though this difference did
not reach statistical significance. Taking into account only
reintervention for failure of graft on RCA system, however,
8-year cumulative incidence of reoperation was similar in
both groups (1.0% in BITA plus SV group vs 0.4% in
BITA plus AC, P¼ .412). Moreover, we registered a signif-
icantly higher cumulative incidence of late sudden death in
the BITA plus AC group (1.2% vs 0.5%, P ¼ .045), which
could well be related to acute graft failure.
Our findings support a more rational use of ACs in the
presence of moderate stenosis in a smaller vascular bed, as
often the RCA system is. In particular, RGEA shows worse
long-term results because of its inability to adapt to high
competitive flow. In this case, SV seems to offer better re-
sult, probably because of its ability to maintain a good
flow.30 Conversely, in presence of high-grade RCA stenosis,
our 8-year outcomes were similar; very likely, however, af-
ter a longer period of observation, RA and RGEA will be
seen to provide better outcomes in this subset of patients.
Limitations of the Study
The main limitation of this study is its retrospective na-
ture. By applying propensity score and sample matching,
however, we were able to reduce selection biases. The diffi-
culty in obtaining angiographic examinations means a lack
of additional information concerning the patency of the
anastomoses and the functional status of the grafts, but
clinical information allows a general conclusion that canCardiovascular Surgery c Volume 137, Number 4 873
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cohort of patients who were operated on in 1990, when pa-
tients scheduled for isolated CABG showed better left ven-
tricular function and fewer comorbidities, and thus it is less
than representative of current routine CABG practice. RA
seems to offer cardiac outcome similar to that of SV; how-
ever, the small sample size of patients with RA limits any
conclusion in this sense. Unfortunately, the retrospective na-
ture of the data does not provide more information on runoff
status and extension of RCA system disease.
CONCLUSIONS
In conclusion, in patients with triple-vessel disease under-
going first isolated CABG, a supplementary SV graft onto
the RCA system seems to provide higher long-term cardiac
survival. This result can be related to the target coronary ste-
nosis; SV yielded better results than RGEA if the stenosis
was less than 80%. The widespread use of antiplatelet
agents and statins places the SV at lower risk for sudden oc-
clusion, with greater likelihood of a slow progression of ath-
erosclerotic processes.
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